When my son was in the second grade, I received a call that changed our lives: “We think he has had a stroke.” At the time, he suddenly developed a facial droop and lost the ability to walk independently. His teacher carried him to the school nurse, with his classmates following anxiously. After urgent medical evaluation, he was diagnosed with metabolic strokes caused by mitochondrial disease, a rare genetic disorder that impairs cells’ ability to produce energy.
To prevent further strokes, his doctors prescribed a regimen of targeted amino acids, antioxidants, and vitamins. However, our insurance denied coverage for these medically essential treatments. Despite having a physician’s prescription, we pay over $500 per month out-of-pocket for his care.
We are far from alone. Nearly 500,000 Americans rely on prescribed medical nutrition at home, which includes specialised formulas, low-protein modified foods, targeted amino acids, and vitamins. These therapies are vital for patients with inherited metabolic disorders such as phenylketonuria and mitochondrial diseases, as well as conditions affecting nutrient absorption, including cystic fibrosis, certain food allergies, and gastrointestinal inflammatory diseases like Crohn’s and ulcerative colitis.
Yet insurance coverage is inconsistent and often insufficient. Because medical foods are regulated differently from drugs, insurers frequently classify them as optional. Coverage varies widely by state, often limited to children or specific diagnoses, and frequently ends in early adulthood—even though these are lifelong medical needs. When coverage stops, the financial burden can be overwhelming, forcing families to discontinue essential treatment.
| Aspect | Details |
|---|---|
| Patient Population | ~500,000 Americans relying on medical nutrition at home |
| Conditions Treated | Inherited metabolic disorders, malabsorption, food allergies, GI inflammatory diseases |
| Monthly Out-of-Pocket Cost | $500+ |
| Insurance Coverage | Inconsistent; often limited to children or early adulthood |
Historically, until 1972, the FDA classified medical foods as drugs. Regulatory reforms then created the category of “foods for special dietary use,” allowing faster innovation in flavours, consistency, and protein sources, improving adherence and accessibility. The Orphan Drug Act of 1988 formally separated medical foods from drugs, inadvertently allowing insurers to treat them as optional rather than medically necessary therapies.
Major medical organisations, including the American College of Medical Genetics and Genomics and the American Academy of Pediatrics, emphasise that these foods are medically essential and should be treated as such. Out-of-pocket costs for families can run into thousands of dollars each month, creating a severe financial strain.
The Medical Foods and Formulas Access Act of 2025, introduced in the House on October 3, 2025, seeks to address this inequity. It would expand coverage under Medicare, Medicaid, CHIP, and the Federal Employees Health Benefits Program, recognising medical foods and associated supplies as essential therapies when prescribed. A companion Senate bill, introduced on December 2, 2025, is also under consideration.
While there is no cure for my son’s rare disease, medical nutrition has prevented further metabolic strokes, reduced hospitalisations, and allowed him to live as a child should. Insurance companies should not be allowed to deny treatments that are lifesaving and prescribed by doctors.
This legislation offers the chance to finally make medical nutrition accessible and protected for all patients in need.